Cargando…

Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors

BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predicto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haomin, Holowko, Natalie, Grassmann, Felix, Eriksson, Mikael, Hall, Per, Czene, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446157/
https://www.ncbi.nlm.nih.gov/pubmed/32838791
http://dx.doi.org/10.1186/s12916-020-01690-y
_version_ 1783574112926433280
author Yang, Haomin
Holowko, Natalie
Grassmann, Felix
Eriksson, Mikael
Hall, Per
Czene, Kamila
author_facet Yang, Haomin
Holowko, Natalie
Grassmann, Felix
Eriksson, Mikael
Hall, Per
Czene, Kamila
author_sort Yang, Haomin
collection PubMed
description BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predictors for breast cancer. METHODS: This study estimates the incidence rate ratios (IRRs) of breast cancer among women diagnosed with hyperthyroidism, compared to those who are not, using two cohorts: a Swedish national cohort of the general female population (n = 3,793,492, 2002–2011) and the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA, n = 69,598, 2002–2017). We used logistic regression to estimate the odds ratios (ORs) of hyperthyroidism according to the mammographic and genetic risk predictors for breast cancer. RESULTS: An increased risk of breast cancer was observed in patients in the national cohort with hyperthyroidism (IRR = 1.23, 95% CI = 1.12–1.36), particularly for toxic nodular goiter (IRR = 1.38, 95% CI = 1.16–1.63). Hyperthyroidism was associated with higher body mass index, early age at first birth, and lower breastfeeding duration. Higher mammographic density was observed in women with toxic nodular goiter, compared to women without hyperthyroidism. Additionally, among genotyped women without breast cancer in the KARMA cohort (N = 11,991), hyperthyroidism was associated with a high polygenic risk score (PRS) for breast cancer overall (OR = 1.98, 95% CI = 1.09–3.60) and for estrogen receptor-positive specific PRS (OR = 1.90, 95% CI = 1.04–3.43). CONCLUSION: Hyperthyroidism is associated with an increased risk of breast cancer, particularly for patients with toxic nodular goiter. The association could be explained by higher mammographic density among these women, as well as pleiotropic genetic variants determining shared hormonal/endocrine factors leading to the pathology of both diseases.
format Online
Article
Text
id pubmed-7446157
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74461572020-08-26 Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors Yang, Haomin Holowko, Natalie Grassmann, Felix Eriksson, Mikael Hall, Per Czene, Kamila BMC Med Research Article BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predictors for breast cancer. METHODS: This study estimates the incidence rate ratios (IRRs) of breast cancer among women diagnosed with hyperthyroidism, compared to those who are not, using two cohorts: a Swedish national cohort of the general female population (n = 3,793,492, 2002–2011) and the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA, n = 69,598, 2002–2017). We used logistic regression to estimate the odds ratios (ORs) of hyperthyroidism according to the mammographic and genetic risk predictors for breast cancer. RESULTS: An increased risk of breast cancer was observed in patients in the national cohort with hyperthyroidism (IRR = 1.23, 95% CI = 1.12–1.36), particularly for toxic nodular goiter (IRR = 1.38, 95% CI = 1.16–1.63). Hyperthyroidism was associated with higher body mass index, early age at first birth, and lower breastfeeding duration. Higher mammographic density was observed in women with toxic nodular goiter, compared to women without hyperthyroidism. Additionally, among genotyped women without breast cancer in the KARMA cohort (N = 11,991), hyperthyroidism was associated with a high polygenic risk score (PRS) for breast cancer overall (OR = 1.98, 95% CI = 1.09–3.60) and for estrogen receptor-positive specific PRS (OR = 1.90, 95% CI = 1.04–3.43). CONCLUSION: Hyperthyroidism is associated with an increased risk of breast cancer, particularly for patients with toxic nodular goiter. The association could be explained by higher mammographic density among these women, as well as pleiotropic genetic variants determining shared hormonal/endocrine factors leading to the pathology of both diseases. BioMed Central 2020-08-25 /pmc/articles/PMC7446157/ /pubmed/32838791 http://dx.doi.org/10.1186/s12916-020-01690-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Haomin
Holowko, Natalie
Grassmann, Felix
Eriksson, Mikael
Hall, Per
Czene, Kamila
Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title_full Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title_fullStr Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title_full_unstemmed Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title_short Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
title_sort hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446157/
https://www.ncbi.nlm.nih.gov/pubmed/32838791
http://dx.doi.org/10.1186/s12916-020-01690-y
work_keys_str_mv AT yanghaomin hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors
AT holowkonatalie hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors
AT grassmannfelix hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors
AT erikssonmikael hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors
AT hallper hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors
AT czenekamila hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors